SIMILAR PATTERNS OF AMINO ACIDS FOR 3K39_C_BCZC1001
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1eqn | DNA PRIMASE (Escherichiacoli) |
PF08275(Toprim_N)PF10410(DnaB_bind)PF13155(Toprim_2) | 5 | ARG A 260GLU A 363ARG A 336ARG A 361GLU A 353 | None | 1.11A | 3k39C-1eqnA:undetectable | 3k39C-1eqnA:21.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1fta | FRUCTOSE-1,6-BISPHOSPHATASE (Homo sapiens) |
PF00316(FBPase) | 5 | ARG A 313LEU A 275GLU A 280GLU A 98GLU A 97 | None | 1.48A | 3k39C-1ftaA:0.7 | 3k39C-1ftaA:22.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG N 118GLU N 119LEU N 134ARG N 152ARG N 156ARG N 224ALA N 246GLU N 276GLU N 277ARG N 292 | None | 0.75A | 3k39C-1nmbN:53.3 | 3k39C-1nmbN:30.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG N 118GLU N 119LEU N 134ARG N 152ARG N 156ARG N 224GLU N 227ALA N 246GLU N 277ARG N 292 | None | 0.82A | 3k39C-1nmbN:53.3 | 3k39C-1nmbN:30.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG N 118GLU N 119LEU N 134ASP N 151ARG N 152ARG N 156ARG N 224GLU N 227GLU N 277ARG N 292 | None | 0.91A | 3k39C-1nmbN:53.3 | 3k39C-1nmbN:30.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1nmb | N9 NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG N 118GLU N 119LEU N 134ASP N 151ARG N 152ARG N 156ARG N 224GLU N 276GLU N 277ARG N 292 | None | 0.85A | 3k39C-1nmbN:53.3 | 3k39C-1nmbN:30.64 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v0z | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 12 | ARG A 124GLU A 125LEU A 140ASP A 157ARG A 158ARG A 162ARG A 231GLU A 234ALA A 253GLU A 283GLU A 284ARG A 299 | None | 0.58A | 3k39C-1v0zA:53.4 | 3k39C-1v0zA:32.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1v0z | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | GLU A 125LEU A 140ASP A 157ARG A 162ARG A 378 | None | 1.44A | 3k39C-1v0zA:53.4 | 3k39C-1v0zA:32.93 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 6 | ARG A 116ASP A 149ARG A 150GLU A 275GLU A 276ARG A 292 | IBA A 1 (-3.3A)IBA A 1 (-3.6A)IBA A 1 (-3.9A)IBA A 1 (-4.1A)IBA A 1 (-3.9A)IBA A 1 (-3.5A) | 1.48A | 3k39C-1vcjA:73.2 | 3k39C-1vcjA:93.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 11 | ARG A 116GLU A 117LEU A 132ASP A 149ARG A 150ARG A 154ARG A 223GLU A 226ALA A 245GLU A 276ARG A 292 | IBA A 1 (-3.3A)IBA A 1 (-3.9A)NoneIBA A 1 (-3.6A)IBA A 1 (-3.9A)IBA A 1 (-4.1A)IBA A 1 ( 4.5A)IBA A 1 (-3.9A)IBA A 1 ( 3.9A)IBA A 1 (-3.9A)IBA A 1 (-3.5A) | 0.70A | 3k39C-1vcjA:73.2 | 3k39C-1vcjA:93.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1vcj | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 5 | GLU A 117LEU A 132ASP A 149ARG A 154ARG A 374 | IBA A 1 (-3.9A)NoneIBA A 1 (-3.6A)IBA A 1 (-4.1A)IBA A 1 (-3.2A) | 1.41A | 3k39C-1vcjA:73.2 | 3k39C-1vcjA:93.57 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 119GLU A 120LEU A 135ASP A 152ARG A 153ARG A 157ARG A 226ALA A 248GLU A 278GLU A 279ARG A 294 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 3.8A)ABW A1000 (-4.1A)ABW A1000 (-4.5A)ABW A1000 (-3.4A) | 0.73A | 3k39C-1xogA:52.7 | 3k39C-1xogA:31.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1xog | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 119GLU A 120LEU A 135ASP A 152ARG A 153ARG A 157ARG A 226GLU A 229ALA A 248GLU A 279ARG A 294 | ABW A1000 (-3.2A)ABW A1000 (-3.7A)NoneABW A1000 (-3.7A)ABW A1000 (-4.1A)ABW A1000 (-4.2A)NoneABW A1000 ( 4.0A)ABW A1000 ( 3.8A)ABW A1000 (-4.5A)ABW A1000 (-3.4A) | 0.77A | 3k39C-1xogA:52.7 | 3k39C-1xogA:31.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1y7y | C.AHDI (Aeromonashydrophila) |
PF01381(HTH_3) | 5 | ARG A 19GLU A 47LEU A 18GLU A 30ARG A 40 | None | 1.41A | 3k39C-1y7yA:undetectable | 3k39C-1y7yA:10.82 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1z6n | HYPOTHETICAL PROTEINPA1234 (Pseudomonasaeruginosa) |
PF14595(Thioredoxin_9) | 5 | ARG A 103LEU A 59ASP A 99ARG A 95GLU A 6 | None | 1.44A | 3k39C-1z6nA:undetectable | 3k39C-1z6nA:16.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2a30 | DEOXYCYTIDINE KINASE (Homo sapiens) |
PF01712(dNK) | 5 | ARG A 128LEU A 208GLU A 196GLU A 197ARG A 194 | DCZ A 302 (-4.1A)NoneNoneDCZ A 302 (-3.5A)DCZ A 302 ( 4.8A) | 1.34A | 3k39C-2a30A:undetectable | 3k39C-2a30A:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2c9e | PERIDININ-CHLOROPHYLL A PROTEIN (Amphidiniumcarterae) |
PF02429(PCP) | 5 | LEU A 252ARG A 42GLU A 49ALA A 111GLU A 53 | None | 1.47A | 3k39C-2c9eA:undetectable | 3k39C-2c9eA:19.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2csd | TOPOISOMERASE V (Methanopyruskandleri) |
PF13412(HTH_24)PF14520(HHH_5) | 5 | ASP A 182ARG A 442ARG A 231GLU A 435GLU A 412 | None | 1.14A | 3k39C-2csdA:undetectable | 3k39C-2csdA:21.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2d5w | PEPTIDE ABCTRANSPORTER,PEPTIDE-BINDINGPROTEIN (Thermusthermophilus) |
PF00496(SBP_bac_5) | 5 | ARG A 550GLU A 304LEU A 547GLU A 465GLU A 419 | None | 1.26A | 3k39C-2d5wA:undetectable | 3k39C-2d5wA:18.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 9 | ARG A 118LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227GLU A 276GLU A 277ARG A 292 | None | 0.88A | 3k39C-2htvA:51.2 | 3k39C-2htvA:35.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 7 | ARG A 118LEU A 134ASP A 151ARG A 152GLU A 227GLU A 276GLU A 277 | None | 1.06A | 3k39C-2htvA:51.2 | 3k39C-2htvA:35.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 8 | GLU A 119LEU A 134ARG A 152ARG A 156ARG A 224GLU A 276GLU A 277ARG A 292 | None | 1.18A | 3k39C-2htvA:51.2 | 3k39C-2htvA:35.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | LEU A 134ARG A 152GLU A 119GLU A 277ARG A 292 | None | 1.02A | 3k39C-2htvA:51.2 | 3k39C-2htvA:35.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2htv | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | LEU A 134ASP A 151ARG A 152GLU A 119GLU A 277 | None | 1.23A | 3k39C-2htvA:51.2 | 3k39C-2htvA:35.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ivf | ETHYLBENZENEDEHYDROGENASEALPHA-SUBUNIT (Aromatoleumaromaticum) |
PF00384(Molybdopterin)PF01568(Molydop_binding) | 5 | GLU A 657LEU A 137ARG A 142ALA A 199GLU A 660 | None | 0.96A | 3k39C-2ivfA:undetectable | 3k39C-2ivfA:17.73 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2lz1 | NUCLEAR FACTORERYTHROID 2-RELATEDFACTOR 2 (Homo sapiens) |
PF03131(bZIP_Maf) | 5 | ARG A 16GLU A 18LEU A 17ARG A 84ALA A 28 | None | 1.19A | 3k39C-2lz1A:undetectable | 3k39C-2lz1A:16.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2r4f | 3-HYDROXY-3-METHYLGLUTARYL-COENZYME AREDUCTASE (Homo sapiens) |
PF00368(HMG-CoA_red) | 5 | GLU A 482ARG A 495ARG A 490ALA A 459GLU A 486 | None | 0.96A | 3k39C-2r4fA:undetectable | 3k39C-2r4fA:21.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2vd3 | ATPPHOSPHORIBOSYLTRANSFERASE (Methanothermobacterthermautotrophicus) |
PF01634(HisG)PF08029(HisG_C) | 5 | ARG A 275LEU A 219ASP A 222ARG A 223GLU A 243 | None | 1.46A | 3k39C-2vd3A:undetectable | 3k39C-2vd3A:23.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2yjq | CEL44C (Paenibacilluspolymyxa) |
PF12891(Glyco_hydro_44) | 5 | GLU A 56LEU A 152ASP A 154ALA A 144GLU A 161 | CA A1521 (-2.1A)None CA A1521 (-3.0A)NoneNone | 1.36A | 3k39C-2yjqA:undetectable | 3k39C-2yjqA:20.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ywb | GMP SYNTHASE[GLUTAMINE-HYDROLYZING] (Thermusthermophilus) |
PF00117(GATase)PF00958(GMP_synt_C) | 5 | ARG A 304LEU A 342ARG A 293GLU A 294ARG A 273 | None | 1.42A | 3k39C-2ywbA:undetectable | 3k39C-2ywbA:21.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3a7s | UBIQUITINCARBOXYL-TERMINALHYDROLASE ISOZYME L5 (Homo sapiens) |
PF01088(Peptidase_C12) | 5 | ARG A 73LEU A 74ARG A 182ALA A 65GLU A 177 | None | 1.46A | 3k39C-3a7sA:undetectable | 3k39C-3a7sA:18.97 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ckz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227GLU A 277ARG A 292 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-3.5A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A) | 0.67A | 3k39C-3ckzA:53.0 | 3k39C-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ckz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 276GLU A 277ARG A 292 | ZMR A 469 (-2.9A)ZMR A 469 (-3.5A)NoneZMR A 469 (-3.5A)ZMR A 469 (-3.9A)ZMR A 469 (-3.4A)ZMR A 469 (-4.4A)ZMR A 469 (-2.8A)ZMR A 469 (-3.7A)ZMR A 469 (-3.0A) | 0.73A | 3k39C-3ckzA:53.0 | 3k39C-3ckzA:34.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ti8 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | LNV A 901 (-3.0A)LNV A 901 (-3.6A)NoneLNV A 901 (-3.4A)LNV A 901 (-4.0A)LNV A 901 (-4.0A)LNV A 901 (-4.1A)LNV A 901 (-3.4A)LNV A 901 (-3.5A)LNV A 901 (-2.9A)LNV A 901 ( 3.8A)LNV A 901 (-2.8A) | 0.54A | 3k39C-3ti8A:53.3 | 3k39C-3ti8A:35.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ti8 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | GLU A 119LEU A 134ASP A 151ARG A 156ARG A 371 | LNV A 901 (-3.6A)NoneLNV A 901 (-3.4A)LNV A 901 (-4.0A)LNV A 901 (-2.9A) | 1.48A | 3k39C-3ti8A:53.3 | 3k39C-3ti8A:35.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tia | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | LNV A 801 (-2.8A)LNV A 801 (-3.5A)NoneLNV A 801 (-3.4A)LNV A 801 (-3.9A)LNV A 801 (-4.0A)LNV A 801 (-4.2A)LNV A 801 (-3.5A)LNV A 801 (-3.4A)LNV A 801 (-2.9A)LNV A 801 (-3.8A)LNV A 801 (-3.0A) | 0.59A | 3k39C-3tiaA:54.7 | 3k39C-3tiaA:29.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3tia | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | GLU A 119LEU A 134ASP A 151ARG A 156ARG A 371 | LNV A 801 (-3.5A)NoneLNV A 801 (-3.4A)LNV A 801 (-4.0A)LNV A 801 (-2.9A) | 1.47A | 3k39C-3tiaA:54.7 | 3k39C-3tiaA:29.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vcn | MANNONATEDEHYDRATASE (Caulobactervibrioides) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 5 | ARG A 148GLU A 340ARG A 284ALA A 172GLU A 170 | CO3 A 503 (-3.9A)CO3 A 503 (-2.6A)CO3 A 503 (-4.0A)NoneNone | 1.42A | 3k39C-3vcnA:undetectable | 3k39C-3vcnA:20.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3vkg | DYNEIN HEAVY CHAIN,CYTOPLASMIC (Dictyosteliumdiscoideum) |
PF03028(Dynein_heavy)PF07728(AAA_5)PF08393(DHC_N2)PF12774(AAA_6)PF12775(AAA_7)PF12777(MT)PF12780(AAA_8)PF12781(AAA_9) | 5 | LEU A2910ASP A2996ARG A2911ALA A3180GLU A3179 | None | 1.24A | 3k39C-3vkgA:undetectable | 3k39C-3vkgA:8.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4a7k | ALDOS-2-ULOSEDEHYDRATASE (Phanerochaetechrysosporium) |
no annotation | 5 | ASP A 283ARG A 279ALA A 315GLU A 228ARG A 314 | None | 1.27A | 3k39C-4a7kA:3.9 | 3k39C-4a7kA:17.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4b7j | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 11 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 225GLU A 228GLU A 277GLU A 278ARG A 293 | G39 A1470 (-3.1A)G39 A1470 (-3.5A)NoneG39 A1470 (-3.7A)G39 A1470 (-3.9A)NoneG39 A1470 (-4.4A)NoneG39 A1470 (-3.7A)G39 A1470 (-4.2A)G39 A1470 (-2.9A) | 0.60A | 3k39C-4b7jA:52.5 | 3k39C-4b7jA:33.33 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4bxs | VENOM PROTHROMBINACTIVATORPSEUTARIN-CNON-CATALYTICSUBUNIT (Pseudonajatextilis) |
PF00754(F5_F8_type_C)PF07732(Cu-oxidase_3) | 5 | GLU V 978LEU V 960ARG V 860GLU V1034ARG V 977 | None | 1.27A | 3k39C-4bxsV:undetectable | 3k39C-4bxsV:14.54 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4cpn | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 12 | ARG A 115GLU A 116LEU A 131ASP A 148ARG A 149ARG A 153ARG A 222GLU A 225ALA A 244GLU A 274GLU A 275ARG A 291 | ZMR A 700 (-2.9A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.3A)ZMR A 700 (-4.0A)ZMR A 700 (-4.2A)ZMR A 700 (-3.8A)ZMR A 700 (-3.5A)ZMR A 700 (-3.6A)ZMR A 700 (-2.7A)ZMR A 700 (-3.4A)ZMR A 700 (-2.8A) | 0.52A | 3k39C-4cpnA:74.0 | 3k39C-4cpnA:96.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4cpn | NEURAMINIDASE (Influenza Bvirus) |
PF00064(Neur) | 5 | ARG A 291GLU A 275GLU A 225ALA A 440GLU A 116 | ZMR A 700 (-2.8A)ZMR A 700 (-3.4A)ZMR A 700 (-3.5A)NoneZMR A 700 (-3.5A) | 1.46A | 3k39C-4cpnA:74.0 | 3k39C-4cpnA:96.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fi4 | MANDELATERACEMASE/MUCONATELACTONIZING PROTEIN (Caulobacter sp.K31) |
PF02746(MR_MLE_N)PF13378(MR_MLE_C) | 5 | ARG A 148GLU A 340ARG A 284ALA A 172GLU A 170 | NoneNone MG A 501 ( 4.8A)NoneNone | 1.44A | 3k39C-4fi4A:undetectable | 3k39C-4fi4A:21.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4frt | PROBABLE PORIN (Pseudomonasaeruginosa) |
PF03573(OprD) | 5 | ASP A 157ARG A 156ARG A 64ALA A 282GLU A 162 | None | 1.47A | 3k39C-4frtA:undetectable | 3k39C-4frtA:22.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4h53 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | SLB A 512 (-2.7A)SLB A 512 (-3.5A)NoneSLB A 512 (-3.5A)SLB A 512 (-3.8A)NoneSLB A 512 (-4.2A)NoneSLB A 512 (-3.3A)SLB A 512 (-2.8A)SLB A 512 (-2.7A)SLB A 512 (-3.1A) | 0.61A | 3k39C-4h53A:54.3 | 3k39C-4h53A:31.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4h53 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | GLU A 119LEU A 134ASP A 151ARG A 156ARG A 371 | SLB A 512 (-3.5A)NoneSLB A 512 (-3.5A)NoneSLB A 512 (-2.9A) | 1.47A | 3k39C-4h53A:54.3 | 3k39C-4h53A:31.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4hxt | DE NOVO PROTEINOR329 (syntheticconstruct) |
PF00514(Arm) | 5 | ARG A 150ARG A 108GLU A 143ALA A 69GLU A 105 | None | 1.34A | 3k39C-4hxtA:undetectable | 3k39C-4hxtA:19.85 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hzz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | G39 A 509 (-3.0A)G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)G39 A 509 (-3.9A)NoneG39 A 509 (-4.7A)NoneG39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A)G39 A 509 (-2.8A) | 0.59A | 3k39C-4hzzA:51.9 | 3k39C-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hzz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | G39 A 509 (-2.9A)G39 A 509 (-4.7A)G39 A 509 ( 4.1A)G39 A 509 ( 4.1A)G39 A 509 ( 4.0A) | 1.40A | 3k39C-4hzzA:51.9 | 3k39C-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4hzz | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | GLU A 119LEU A 134ASP A 151ARG A 156ARG A 371 | G39 A 509 (-3.3A)NoneG39 A 509 (-3.6A)NoneG39 A 509 (-2.9A) | 1.48A | 3k39C-4hzzA:51.9 | 3k39C-4hzzA:34.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 10 | ARG A 118LEU A 134ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | 27S A 501 (-3.0A)None27S A 501 (-4.2A)None27S A 501 (-4.3A)27S A 501 (-3.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 0.71A | 3k39C-4mjuA:51.4 | 3k39C-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 6 | ARG A 118LEU A 134ASP A 151ARG A 152ARG A 156GLU A 277 | 27S A 501 (-3.0A)None27S A 501 (-3.2A)27S A 501 (-4.2A)None27S A 501 (-3.4A) | 0.90A | 3k39C-4mjuA:51.4 | 3k39C-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | ARG A 371ARG A 224ALA A 246GLU A 276GLU A 277 | 27S A 501 (-3.1A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A) | 1.42A | 3k39C-4mjuA:51.4 | 3k39C-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 8 | GLU A 119LEU A 134ARG A 152ARG A 224ALA A 246GLU A 276GLU A 277ARG A 292 | 27S A 501 (-3.4A)None27S A 501 (-4.2A)27S A 501 (-4.3A)27S A 501 ( 3.8A)27S A 501 ( 3.7A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.08A | 3k39C-4mjuA:51.4 | 3k39C-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 7 | LEU A 134ARG A 152ARG A 156GLU A 119ALA A 246GLU A 277ARG A 292 | None27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 ( 3.8A)27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.00A | 3k39C-4mjuA:51.4 | 3k39C-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 6 | LEU A 134ASP A 151ARG A 152ARG A 156GLU A 119GLU A 277 | None27S A 501 (-3.2A)27S A 501 (-4.2A)None27S A 501 (-3.4A)27S A 501 (-3.4A) | 1.19A | 3k39C-4mjuA:51.4 | 3k39C-4mjuA:34.84 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4mju | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 5 | LEU A 134ASP A 151ARG A 156GLU A 119ARG A 371 | None27S A 501 (-3.2A)None27S A 501 (-3.4A)27S A 501 (-3.1A) | 1.46A | 3k39C-4mjuA:51.4 | 3k39C-4mjuA:34.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nhu | H-2 CLASS IHISTOCOMPATIBILITYANTIGEN, L-D ALPHACHAIN (Mus musculus) |
PF00129(MHC_I) | 5 | ARG E 97GLU E 114LEU E 126ALA E 167GLU E 163 | None | 1.48A | 3k39C-4nhuE:undetectable | 3k39C-4nhuE:18.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4qn3 | NEURAMINIDASE (Influenza Avirus) |
PF00064(Neur) | 12 | ARG A 36GLU A 37LEU A 52ASP A 69ARG A 70ARG A 74ARG A 143GLU A 146ALA A 165GLU A 195GLU A 196ARG A 211 | None | 0.64A | 3k39C-4qn3A:53.2 | 3k39C-4qn3A:32.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rv1 | ENGINEERED PROTEINOR497 (syntheticconstruct) |
PF00514(Arm) | 5 | ARG A 192ARG A 150GLU A 185ALA A 111GLU A 147 | None | 1.34A | 3k39C-4rv1A:undetectable | 3k39C-4rv1A:21.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rv1 | ENGINEERED PROTEINOR497 (syntheticconstruct) |
PF00514(Arm) | 5 | ARG A 276ARG A 234GLU A 269ALA A 195GLU A 231 | None | 1.46A | 3k39C-4rv1A:undetectable | 3k39C-4rv1A:21.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4rv1 | ENGINEERED PROTEINOR497 (syntheticconstruct) |
PF00514(Arm) | 5 | ARG A 402ARG A 360GLU A 395ALA A 321GLU A 357 | None | 1.36A | 3k39C-4rv1A:undetectable | 3k39C-4rv1A:21.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4xym | BETA SUBUNIT OFACYL-COA SYNTHETASE(NDP FORMING) (CandidatusKorarchaeumcryptofilum) |
PF13549(ATP-grasp_5) | 5 | ARG B 51GLU B 44ALA B 88GLU B 43ARG B 90 | None | 1.41A | 3k39C-4xymB:undetectable | 3k39C-4xymB:20.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5dot | CARBAMOYL-PHOSPHATESYNTHASE [AMMONIA],MITOCHONDRIAL (Homo sapiens) |
PF00117(GATase)PF00988(CPSase_sm_chain)PF02142(MGS)PF02786(CPSase_L_D2)PF02787(CPSase_L_D3) | 5 | ARG A 929ASP A 914ARG A 814GLU A1034ARG A1039 | NoneNoneEDO A1603 (-3.9A)EDO A1603 (-2.7A)EDO A1603 ( 3.8A) | 1.36A | 3k39C-5dotA:undetectable | 3k39C-5dotA:13.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5g2v | N-ACETYLGLUCOSAMINE-6-SULFATASE (Bacteroidesthetaiotaomicron) |
PF00884(Sulfatase)PF16347(DUF4976) | 5 | GLU A 446ASP A 361ARG A 200ALA A 75GLU A 442 | SGN A1522 (-2.9A)SGN A1522 (-2.8A)SGN A1522 (-3.6A)NoneNone | 1.49A | 3k39C-5g2vA:undetectable | 3k39C-5g2vA:21.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5hlb | PENICILLIN-BINDINGPROTEIN 1B (Escherichiacoli) |
PF00905(Transpeptidase)PF00912(Transgly)PF14814(UB2H) | 5 | LEU A 128ASP A 198ARG A 156GLU A 340GLU A 341 | None | 1.39A | 3k39C-5hlbA:undetectable | 3k39C-5hlbA:19.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5iy3 | GENOME POLYPROTEIN (Zika virus) |
PF00948(Flavi_NS1) | 5 | ARG A 211LEU A 212ARG A 214ARG A 276GLU A 278 | None | 0.80A | 3k39C-5iy3A:undetectable | 3k39C-5iy3A:22.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jxr | CHROMATIN-REMODELINGCOMPLEX ATPASE-LIKEPROTEIN (Thermothelomycesthermophila) |
PF00176(SNF2_N)PF00271(Helicase_C) | 5 | GLU A 157LEU A 161GLU A 132GLU A 156ARG A 136 | None | 1.39A | 3k39C-5jxrA:undetectable | 3k39C-5jxrA:18.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5k6o | B-GLUCOSIDASE (metagenome) |
PF00933(Glyco_hydro_3)PF01915(Glyco_hydro_3_C)PF14310(Fn3-like) | 5 | LEU A 582ASP A 532ARG A 538GLU A 600ARG A 597 | NoneGAL A1000 (-3.1A)GAL A1000 (-4.4A)NoneGAL A1000 (-3.1A) | 1.50A | 3k39C-5k6oA:undetectable | 3k39C-5k6oA:17.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kbr | SERINE/THREONINE-PROTEIN KINASE PAK 1 (Homo sapiens) |
PF00069(Pkinase) | 5 | GLU A 434ARG A 509ARG A 388ALA A 412GLU A 423 | None | 1.35A | 3k39C-5kbrA:undetectable | 3k39C-5kbrA:20.57 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nd1 | CAPSID PROTEIN (Rosellinianecatrixquadrivirus 1) |
no annotation | 5 | GLU A 740LEU A 478ASP A 472ARG A 627ARG A 471 | None | 1.49A | 3k39C-5nd1A:undetectable | 3k39C-5nd1A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5oas | MALATE SYNTHASE G (Pseudomonasaeruginosa) |
no annotation | 5 | ARG A 422GLU A 415LEU A 425ARG A 450ALA A 41 | None | 1.32A | 3k39C-5oasA:undetectable | 3k39C-5oasA:19.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5wug | BETA-GLUCOSIDASE (Paenibacillusbarengoltzii) |
no annotation | 5 | LEU A 620ASP A 570ARG A 576GLU A 638ARG A 635 | None | 1.44A | 3k39C-5wugA:undetectable | 3k39C-5wugA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6br6 | NEURAMINIDASE (Influenza Avirus) |
no annotation | 12 | ARG A 118GLU A 119LEU A 134ASP A 151ARG A 152ARG A 156ARG A 224GLU A 227ALA A 246GLU A 276GLU A 277ARG A 292 | E3M A 511 (-3.0A)E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)E3M A 511 (-3.8A)NoneE3M A 511 (-3.8A)E3M A 511 ( 4.8A)E3M A 511 (-3.1A)E3M A 511 (-2.3A)E3M A 511 ( 3.6A)E3M A 511 (-2.9A) | 0.64A | 3k39C-6br6A:53.9 | 3k39C-6br6A:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6br6 | NEURAMINIDASE (Influenza Avirus) |
no annotation | 5 | GLU A 119LEU A 134ASP A 151ARG A 156ARG A 371 | E3M A 511 (-3.6A)NoneE3M A 511 (-2.9A)NoneE3M A 511 (-2.9A) | 1.45A | 3k39C-6br6A:53.9 | 3k39C-6br6A:undetectable |